BA
Bristlecone Advisors Portfolio holdings
AUM
$1.19B
1-Year Return
17.36%
This Quarter Return
+0.56%
1 Year Return
+17.36%
3 Year Return
+78.93%
5 Year Return
+115.97%
10 Year Return
–
AUM
$271M
AUM Growth
+$18.5M
(+7.3%)
Cap. Flow
+$25.1M
Cap. Flow
% of AUM
9.26%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
165
New
4
Increased
66
Reduced
50
Closed
29
Top Buys
| 1 |
Schwab US Aggregate Bond ETF
SCHZ
|
$11.2M |
| 2 |
Apple
AAPL
|
$5.53M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$4.45M |
| 4 |
Microsoft
MSFT
|
$3.27M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$3.22M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$3.48M |
| 2 |
PACCAR
PCAR
|
$3.47M |
| 3 |
Johnson & Johnson
JNJ
|
$2.9M |
| 4 |
Gilead Sciences
GILD
|
$2.28M |
| 5 |
Schlumberger
SLB
|
$2.1M |
Sector Composition
| 1 | Technology | 12.63% |
| 2 | Healthcare | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 6.95% |
| 5 | Consumer Discretionary | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares US Real Estate ETF
IYR
$3.76B
| $235K | 0.09% |
2,857
+156
| +6% | +$12.8K |
|
127
Weyerhaeuser
WY
$18.8B
| $234K | 0.09% |
7,873
-326
| -4% | -$9.69K |
|
128
Merck
MRK
$211B
| $231K | 0.09% |
4,205
-534
| -11% | -$29.3K |
|
129
iShares Core US Aggregate Bond ETF
AGG
$132B
| $230K | 0.08% |
+2,039
| New | +$230K |
|
130
AT&T
T
$211B
| $229K | 0.08% |
7,029
-2,451
| -26% | -$79.9K |
|
131
Vanguard Mega Cap 300 Index ETF
MGC
$7.7B
| $219K | 0.08% |
3,061
+12
| +0.4% | +$859 |
|
132
Vanguard FTSE All-World ex-US ETF
VEU
$48.8B
| $218K | 0.08% |
5,090
-5,525
| -52% | -$237K |
|
133
Dollar Tree
DLTR
$20.2B
| $215K | 0.08% |
2,284
-465
| -17% | -$43.8K |
|
134
Valero Energy
VLO
$48.1B
| $210K | 0.08% |
4,110
-715
| -15% | -$36.5K |
|
|
S
135
DELISTED
Sprint Corporation
S
| $59K | 0.02% |
13,087
| – | – |
|
|
MDVL
136
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $56K | 0.02% |
48
| – | – |
|
137
Abbott
ABT
$232B
| – | – |
-5,293
| Closed | -$221K |
|
138
Aptiv
APTV
$17.5B
| – | – |
-18,630
| Closed | -$1.4M |
|
139
Blackrock
BLK
$170B
| – | – |
-5,010
| Closed | -$1.71M |
|
140
Bristol-Myers Squibb
BMY
$95.3B
| – | – |
-3,990
| Closed | -$255K |
|
141
ConocoPhillips
COP
$117B
| – | – |
-17,740
| Closed | -$714K |
|
142
Danaher
DHR
$144B
| – | – |
-6,511
| Closed | -$415K |
|
143
Ecolab
ECL
$77.9B
| – | – |
-16,750
| Closed | -$1.87M |
|
|
144
Gilead Sciences
GILD
$143B
| – | – |
-24,787
| Closed | -$2.28M |
|
145
Helmerich & Payne
HP
$2.03B
| – | – |
-10,625
| Closed | -$624K |
|
146
Ingredion
INGR
$8.25B
| – | – |
-3,350
| Closed | -$358K |
|
|
147
Johnson & Johnson
JNJ
$431B
| – | – |
-26,820
| Closed | -$2.9M |
|
148
Kraft Heinz
KHC
$32.2B
| – | – |
-2,570
| Closed | -$202K |
|
149
Coca-Cola
KO
$294B
| – | – |
-8,419
| Closed | -$391K |
|
150
Northrop Grumman
NOC
$82.5B
| – | – |
-9,719
| Closed | -$1.92M |
|